Hal Chapman
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect (NCT06265532) | Hal Chapman | 2024-02-07 |
| Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients (NCT05195918) | Hal Chapman | 2023-08-24 |
| Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis. (NCT03928847) | Hal Chapman | 2017-12-01 |
Track Hal Chapman automatically
Every clearance here is in the API, with alerts when new ones post.